PL367293A1 - Zastosowanie izowalerylo L-karnityny w przygotowaniu leku stosowanego w zapobieganiu i leczeniu osteoporozy - Google Patents
Zastosowanie izowalerylo L-karnityny w przygotowaniu leku stosowanego w zapobieganiu i leczeniu osteoporozyInfo
- Publication number
- PL367293A1 PL367293A1 PL01367293A PL36729301A PL367293A1 PL 367293 A1 PL367293 A1 PL 367293A1 PL 01367293 A PL01367293 A PL 01367293A PL 36729301 A PL36729301 A PL 36729301A PL 367293 A1 PL367293 A1 PL 367293A1
- Authority
- PL
- Poland
- Prior art keywords
- isovaleryl
- carnitine
- osteoporosis
- cure
- medicament
- Prior art date
Links
- IGQBPDJNUXPEMT-SNVBAGLBSA-N isovaleryl-L-carnitine Chemical compound CC(C)CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C IGQBPDJNUXPEMT-SNVBAGLBSA-N 0.000 title abstract 2
- 208000001132 Osteoporosis Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 230000001582 osteoblastic effect Effects 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2000RM000688A IT1317079B1 (it) | 2000-12-21 | 2000-12-21 | Uso della isovaleril l-carnitina per la preparazione di un medicamentoper la prevenzione e cura dell'osteoporosi. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL367293A1 true PL367293A1 (pl) | 2005-02-21 |
| PL207879B1 PL207879B1 (pl) | 2011-02-28 |
Family
ID=11455074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL367293A PL207879B1 (pl) | 2000-12-21 | 2001-12-04 | Zastosowanie izowalerylo L-karnityny lub jej farmakologicznie dopuszczalnej soli do otrzymywania leku |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US6906102B2 (pl) |
| EP (1) | EP1351676B1 (pl) |
| AT (1) | ATE301998T1 (pl) |
| AU (1) | AU2002217431A1 (pl) |
| CA (1) | CA2434962C (pl) |
| CZ (1) | CZ304356B6 (pl) |
| DE (1) | DE60112802T2 (pl) |
| DK (1) | DK1351676T3 (pl) |
| ES (1) | ES2247005T3 (pl) |
| HU (1) | HU227342B1 (pl) |
| IT (1) | IT1317079B1 (pl) |
| MX (1) | MXPA03006332A (pl) |
| PL (1) | PL207879B1 (pl) |
| SK (1) | SK287306B6 (pl) |
| WO (1) | WO2002049639A1 (pl) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1290801B1 (it) * | 1996-07-05 | 1998-12-11 | Mendes Srl | Uso della acetil l-carnitina, della isovaleril l-carnitina, della propionil l-carnitina o dei loro sali farmacologicamente accettabili |
| IT1291141B1 (it) * | 1997-04-16 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica comprendente una alcanoil l-carnitina, atta a stimolare la moltiplicazione e la crescita degli osteoblasti |
| IT1299191B1 (it) | 1998-06-23 | 2000-02-29 | Sigma Tau Healthscience Spa | Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa |
-
2000
- 2000-12-21 IT IT2000RM000688A patent/IT1317079B1/it active
-
2001
- 2001-12-04 SK SK891-2003A patent/SK287306B6/sk not_active IP Right Cessation
- 2001-12-04 DK DK01271219T patent/DK1351676T3/da active
- 2001-12-04 AT AT01271219T patent/ATE301998T1/de active
- 2001-12-04 PL PL367293A patent/PL207879B1/pl unknown
- 2001-12-04 DE DE60112802T patent/DE60112802T2/de not_active Expired - Lifetime
- 2001-12-04 AU AU2002217431A patent/AU2002217431A1/en not_active Abandoned
- 2001-12-04 CA CA2434962A patent/CA2434962C/en not_active Expired - Fee Related
- 2001-12-04 CZ CZ2003-1890A patent/CZ304356B6/cs not_active IP Right Cessation
- 2001-12-04 US US10/470,158 patent/US6906102B2/en not_active Expired - Fee Related
- 2001-12-04 MX MXPA03006332A patent/MXPA03006332A/es active IP Right Grant
- 2001-12-04 ES ES01271219T patent/ES2247005T3/es not_active Expired - Lifetime
- 2001-12-04 HU HU0400735A patent/HU227342B1/hu not_active IP Right Cessation
- 2001-12-04 WO PCT/IT2001/000614 patent/WO2002049639A1/en not_active Ceased
- 2001-12-04 EP EP01271219A patent/EP1351676B1/en not_active Expired - Lifetime
-
2005
- 2005-01-11 US US11/032,019 patent/US7084174B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| SK287306B6 (sk) | 2010-06-07 |
| IT1317079B1 (it) | 2003-05-26 |
| WO2002049639A1 (en) | 2002-06-27 |
| HUP0400735A2 (hu) | 2004-07-28 |
| US6906102B2 (en) | 2005-06-14 |
| PL207879B1 (pl) | 2011-02-28 |
| ATE301998T1 (de) | 2005-09-15 |
| HU227342B1 (en) | 2011-04-28 |
| ITRM20000688A1 (it) | 2002-06-21 |
| DE60112802D1 (de) | 2005-09-22 |
| AU2002217431A1 (en) | 2002-07-01 |
| ES2247005T3 (es) | 2006-03-01 |
| CZ20031890A3 (cs) | 2004-04-14 |
| DK1351676T3 (da) | 2005-12-19 |
| CZ304356B6 (cs) | 2014-03-26 |
| MXPA03006332A (es) | 2004-04-21 |
| CA2434962C (en) | 2010-02-09 |
| DE60112802T2 (de) | 2006-03-16 |
| EP1351676B1 (en) | 2005-08-17 |
| SK8912003A3 (en) | 2003-11-04 |
| CA2434962A1 (en) | 2002-06-27 |
| HUP0400735A3 (en) | 2009-01-28 |
| US20050143458A1 (en) | 2005-06-30 |
| US20040077718A1 (en) | 2004-04-22 |
| EP1351676A1 (en) | 2003-10-15 |
| ITRM20000688A0 (it) | 2000-12-21 |
| US7084174B2 (en) | 2006-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0100437A2 (hu) | Szabályzott felszabadulású gyógyszerkészítmény tolterodin adagolására | |
| WO1994027589A3 (en) | Antidepressant dosage form | |
| NO20101190L (no) | Anvendelse av buprenorfin i fremstillingen av et medikament | |
| HUP0000558A3 (en) | Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases | |
| WO2001078698A3 (en) | Use of ngf-antagonists for the prevention or treatment of chronic visceral pain | |
| AU7031500A (en) | Therapeutic quinazoline compounds | |
| PL338982A1 (en) | Drug for improving duration of muscle action or for treating muscular disorders or diseases | |
| EP1250127A4 (en) | METHOD OF ADMINISTERING A MEDICAL AEROSOL FORMULATION | |
| MY164077A (en) | Compositions and uses of et743 for treating cancer | |
| PT1001802E (pt) | Preparacao farmaceutica combinada compreendendo a hormona da paratiroide e um inibidor de reabsorcao ossea | |
| MXPA04001912A (es) | Aminobenzofenonas novedosas. | |
| PL367293A1 (pl) | Zastosowanie izowalerylo L-karnityny w przygotowaniu leku stosowanego w zapobieganiu i leczeniu osteoporozy | |
| WO2002030955A3 (en) | Tetrapeptide stimulating functional activity of hepatocytes and its therapeutical use | |
| AU2003249472A8 (en) | Use of angelicin and of its structural analogues for the treatment of thalassemia | |
| AU2003281257A8 (en) | A novel use of rapamycin and structural analogues thereof | |
| AU4258601A (en) | Divided dose therapies with vascular damaging activity | |
| WO2003072019A3 (en) | Sequential therapy comprising a 20(s)-camptothecin compound and a pyrimidine base analog | |
| ZA95908B (en) | A synergistic formulation for treatment of rheumatic diseases | |
| IL156144A0 (en) | Novel therapeutic use of a thienylcyclohexylamine derivative | |
| AU2002211217A1 (en) | Method of treating stroke | |
| WO1998031355A3 (en) | Pharmaceutical composition comprising n-propylnorapomorphine and cathecol-o-methyl-transferase inhibitor for treating parkinson's disease | |
| MXPA03010919A (es) | Uso de acetil l-carnitina para preparacion de medicamento para terapia preventiva del dolor. | |
| GB0208129D0 (en) | Method of treatment | |
| MD1469G2 (ro) | Metodă de tratament al şocului combustional | |
| AU2002238405A1 (en) | Pharmaceutical formulation and the use thereof for preparing a medicament for the treatment of cardiovascular diseases |